Back to Trades
Sell4
Vera Therapeutics, Inc.
VERA
Total Value
$1.0M
Net $1.0M sold
Sales
$1.0M
3 transactions
Company Information
- Company Name
- Vera Therapeutics, Inc.
- Ticker Symbol
- VERA
- CIK
- 0001831828
Insider Information
- Name
- Fordyce Marshall
- Role
- Insider
- Location
- BRISBANE, CA
Filing Details
- Filing Date
- Apr 15, 2026
- Transaction Date
- Apr 14, 2026
- Accession Number
- 0001859453-26-000006
- Form Type
- 4
- Net Trading Amount
- -$1.0M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 14, 2026 | Class A Common Stock | 14,130 | $43.66 | Sale | $617.0K |
| Apr 14, 2026 | Class A Common Stock | 7,921 | $44.58 | Sale | $353.1K |
| Apr 14, 2026 | Class A Common Stock | 900 | $45.51 | Sale | $41.0K |
Footnotes
- (F1)This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended,
- (F2)The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.25 to $44.24, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- (F3)Includes 1,032 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on March 13, 2026.
- (F4)The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.25 to $45.20, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- (F5)The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $45.25 to $45.67, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.